BIMZELX® (bimekizumab injection) Receives Positive Reimbursement Recommendation from Canada's Drug Agency for Hidradenitis Suppurativa

CNW/ - UCB Canada Inc. today announced that Canada's Drug Agency (CDA-AMC) has issued a positive recommendation to reimburse ...
Yahoo Finance

PrBIMZELX® (bimekizumab injection) receives positive reimbursement recommendation from INESSS for adults living with moderate to severe hidradenitis suppurativa (HS)

This recommendation represents a meaningful step toward broadening access to Pr BIMZELX ® (bimekizumab injection) for eligible Canadian patients living with HS in Quebec. UCB Canada Inc. Logo (CNW ...
Yahoo Finance

BIMZELX® (bimekizumab) Negotiations with pCPA Concluded Successfully Following Positive CDA and INESSS Recommendations for Adults with Active Psoriatic Arthritis and Adults ...

"At UCB, we envision a world where all patients in need have access to our therapies," said Andrea Loewendorf, Head, Immunology Business Unit, UCB Canada. "We are pleased and proud of the positive ...
Pharmabiz

Health Canada approves UCB's Cimzia to treat non-radiographic axial spondyloarthritis

UCB Canada announced that Health Canada has approved Cimzia (certolizumab pegol) for the treatment of adults with severe active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs ...
Reuters

UCB Canada Says Data From Phase 3 Be Vivid, Be Ready Studies Show Bimekizumab-Treated Patients With Psoriasis Showed Significant Skin Clearance At Week 16

* UCB CANADA - FULL RESULTS FROM PLACEBO AND ADALIMUMAB COMPARATOR BE SURE STUDY TO BE PRESENTED AT A FUTURE SCIENTIFIC CONGRESS * UCB CANADA- PHASE 3 TRIALS OF BIMEKIZUMAB IN PSORIATIC ARTHRITIS, ...
Burlington Post

UCB Pharma Canada launches scholarship program

The Burlington-based Canadian arm of a global biopharmaceutical company has launched a scholarship program aimed specifically at students with either Crohn’s disease or rheumatoid arthritis. UCB ...